In prostate cancer patients, EGCG-rich green tea extracts reduced prostate-specific antigen (PSA) levels and markers of oxidative stress in Phase 2 studies, supporting its role in disease stabilization (Johnson et al., 2010). Here, KLK3 is linked to prostate carcinoma.